AlphAIalphai — Financial news for AI agents
investing.comAUG 184 min read$WEAV

Francisco Partners to acquire Weave Communications for $650M

Weave Communications (NYSE:WEAV) shares rose 32.7% premarket after Francisco Partners agreed to acquire the company for about $650M. Weave stockholders will receive $7.40 per share in cash, a ~34% premium to Aug. 17 close. Weave will delist and become private; deal expected Q4 2026, subject to approvals.

Original reporting
investing.com
Published Aug 18, 2026, 1:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 1:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefMergers & acquisitions
Primary signal
$WEAV
Bullish
high confidence
Mentioned
$WEAV
Relevance
9/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$WEAVBullishHigh
01

Why it matters

The offer price ($7.40) and premium (about 34%) create a clear valuation anchor for traders, while the expected Q4 2026 close sets a multi-month catalyst path tied to approvals and shareholder voting.

02

Market read

A new, fully specified M&A offer with a stated premium and expected delisting is a direct driver for deal-arb positioning and risk management.

03

What to watch

No details are provided on financing, antitrust/regulatory likelihood, or any competing bids, which are key for deal-spread risk.

Relevance 9/10Novelty 9/10Timing: premarket today after the acquisition announcement

Background

Weave is an AI-powered patient engagement and payments platform serving 40,000+ locations, and the board has recommended the transaction.

Company-level read

Ticker impact

$WEAVBullishHigh confidence
Context

Weave announced Francisco Partners will acquire it for about $650M, paying $7.40 per share and taking it private after NYSE delisting.

Expected impact

Expect continued deal-spread volatility and upside bias toward the offer price, with pullbacks on any regulatory or shareholder-vote friction.

Evidence & confidence

The article provides concrete offer price, premium, and expected delisting/private status, which are primary drivers of deal-arb pricing and risk.

Market effects

Sector

Healthcare payments and patient engagement software names may see read-through interest, but the article is primarily company-specific.

Regional

Limited, as the transaction is US-focused and the target is a single issuer.

Global

Low, since the deal is not described as cross-border or systemically important.

Counterpoint

What could challenge this read

The stock’s move may fade if deal conditions (regulatory approvals or shareholder vote) introduce uncertainty, widening the spread versus the $7.40 offer.

Key entities

  • company
    Weave Communications

    Target company being acquired; will cease trading on NYSE and become private after completion.

  • acquirer
    Francisco Partners

    Private equity firm acquiring Weave for approximately $650M under the agreement.

  • governance
    Weave Board of Directors

    Unanimously approved the transaction and recommends stockholders vote in favor.

Read at source← All news

Related articles

AUG 14
$WEAVMedAI 8/10

Weave (WEAV) Q2 2026 Earnings Call Transcript

Weave (WEAV) reported Q2 2026 revenue of $67.5 million, up 15.5% year over year, with payments revenue growing about twice as fast. Non-GAAP operating income rose to $3.2 million and margin to 4.7%. Management raised FY2026 operating income guidance to $12 million to $14 million and updated revenue guidance to $273 million to $275 million, citing sales transition impacts on bookings.

fool.com6 min
AUG 9
$WEAVMedAI 8/10

Weave Communications Q2 Earnings Call Highlights

Weave Communications (NYSE:WEAV) reported Q2 expense ratios and ended the quarter with $78.5M cash and short-term investments. It generated $10.2M operating cash flow and $8.7M free cash flow, with positive FCF in H1 2026. The company reorganized its go-to-market model, causing May-July booking shortfalls. Full-year revenue guidance is $273M-$275M and non-GAAP operating income $12M-$14M.

yahoo.com6 min
AUG 6
$WEAVMed

Weave Communications, Inc. (WEAV): Results of Operations and Financial Condition

Weave Communications, Inc. (WEAV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a991-weaveearningsreleasex.htm EX-99.1 Document Weave Announces Second Quarter 2026 Financial Results • Second quarter total revenue of $67.5 million, up 15.5% year over year • Second quarter GAAP gross margin of 72.0%, up 30 basis points year over year • Second quarter

SEC EDGAR 8-K6 min
AUG 18
$BMRNHighAI 9/10

Why is BioMarin Pharmaceutical stock surging today?

BioMarin Pharmaceutical (BMRN) shares rose 4.7% pre-open after the company said it will acquire Alesta Therapeutics for $275 million upfront plus up to $215 million in development and regulatory milestones, funded from cash on hand. The deal adds ALE1, an oral Phase 1/2a asset for hypophosphatasia. Barclays and Piper Sandler raised price targets.

investing.com4 min
AUG 18
$ONDSMedAI 8/10

Why is Ondas stock sliding today?

Investing.com reports Ondas (ONDS) shares fell about 4.8% pre-open after the company agreed to buy Aran Defense Ltd., a division of Aran Ltd., for about $33 million in cash or Ondas stock. The deal is set to close in Q3 2026. Ondas recently posted Q2 2026 revenue of $83.8 million and raised its FY target to $525–$550 million, but adjusted EPS loss was about double consensus.

investing.com4 min
Francisco Partners to acquire Weave Communications for $650M — alphai